Black Swan Sale

50% Off Elite

Register Now!

Get our most powerful screeners, new charting tools, and the fastest ad-
free experience at our best price ever. This deal may never happen again.

Last Close
Nov 28  •  02:40PM ET
35.74
Dollar change
-0.23
Percentage change
-0.64
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y33.74% Total Holdings55 Perf Week5.06%
SponsorTema ETF Type Tagsequity Return% 3Y- AUM105.22M Perf Month16.65%
Fund Family Bond Type Tagshealthcare Return% 5Y- NAV/sh Perf Quarter34.15%
Index- Average Maturity Tags- Return% 10Y 52W High36.08 -0.93% Perf Half Y47.21%
Index Weighting Commodity Type Tags- Return% SI 52W Low20.10 77.87% Perf YTD47.04%
Active/Passive Quant Type Tags- Flows% 1M5.14% Volatility1.89% 1.82% Perf Year32.28%
Dividend TTM0.50 (1.40%) ESG Type Tags- Flows% 3M9.82% ATR (14)0.64 Perf 3Y-
Dividend Ex-DateDec 11, 2024 Dividend Type Sector/Theme Flows% YTD33.36% RSI (14)81.32 Perf 5Y-
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta0.93 Perf 10Y-
Expense0.75% Growth/Value SMA208.30% Flows% 3Y Rel Volume1.33 Prev Close35.97
Inverse/Leveraged Market Cap SMA5016.06% Flows% 5Y Avg Volume12.22K Price35.74
IPOAug 16, 2023 Option/ShortNo / No SMA20034.47% Trades Volume16,229 Change-0.64%
Nov-26-25 10:00AM
Nov-21-25 08:00AM
Oct-20-25 06:00AM
Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.